Audiology and Neurotology

Original Paper

Progressive Hearing Loss in Mice with a Mutated Vitamin D Receptor Gene

Zou J.a · Minasyan A.b · Keisala T.b · Zhang Y.a · Wang J.-H.b · Lou Y.-R.b · Kalueff A.b · Pyykkö I.a · Tuohimaa P.b, c

Author affiliations

Departments of aOtolaryngology, and bAnatomy, School of Medicine, University of Tampere, cDepartment of Clinical Chemistry, Tampere University Hospital, Tampere, Finland

Related Articles for ""

Audiol Neurotol 2008;13:219–230

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: July 13, 2007
Accepted: October 19, 2007
Published online: February 07, 2008
Issue release date: June 2008

Number of Print Pages: 12
Number of Figures: 6
Number of Tables: 1

ISSN: 1420-3030 (Print)
eISSN: 1421-9700 (Online)

For additional information: https://www.karger.com/AUD

Abstract

Background: Both hypo- and hypervitaminosis D can cause sensorineural hearing loss, and aural symptoms due to vitamin D insufficiency are especially common during gravidity. Hormonal forms of vitamin D regulate transcription by binding with the high-affinity vitamin D receptor (VDR). Objective: To assess the effects of impaired vitamin D action in VDR knockout (KO) mice on hearing, cochlear morphology, and cochlear gene expression. Materials and Methods: Eighteen young male and female mice (10 VDR KO and 8 wild type, WT, ≤6 months old), 33 adult male and female mice (16 VDR KO and 17 WT, between 7 and 14 months old), and 11 aged male and female mice (5 VDR KO and 6 WT, ≧15 months old) on 129S1 genetic background were studied. Auditory thresholds were evaluated by auditory brain stem response. Morphological changes were analyzed using plastic embedding and light microscopy. The expression of key genes (known to play a role in the regulation of cochlear function), and caspase 3 activity, were assessed using immunofluorescent confocal microscopy. Results: There was a statistically significant difference between the young and the adult groups, and between the adult and aged groups of WT mice. There was also a statistically significant difference between the adult and aged groups in VDR KO mice, and between the young WT group and the young VDR KO group. Spiral ganglion cell loss was observed in the basal turn of adult VDR KO mice, a phenomenon infrequently found in WT mice. Expression of connexin 26, KCNJ10, and transient receptor potential channel vanilloid subfamily 4/6 was not affected by VDR KO-mediated hearing loss. Caspase 3 activation was detected in the spiral ganglion cell and its satellite cells, stria vascularis, spiral ligament fibrocytes, and the organ of Corti in both genotypes. However, the percentage of positive cells and the staining intensity were lower in the VDR KO (compared to the WT) mice. Conclusion: These data suggest that sensorineural hearing loss progressively developed at an earlier age in VDR KO mice. While the fundamental gene expressions in the cochlea were not influenced by VDR mutation, it resulted in decrease of caspase 3 activation, which may be one of the factors underlying accelerating age-related hearing loss observed in VDR KO mice.

© 2008 S. Karger AG, Basel




Related Articles:


References

  1. Bouillon R, Verstuyf A, Mathieu C, Van Cromphaut S, Masuyama R, Dehaes P, Carmeliet G: Vitamin D resistance. Best Pract Res Clin Endocrinol Metab 2006;20:627–645.
  2. Brookes GB: Vitamin D deficiency – a new cause of cochlear deafness. J Laryngol Otol 1983;97:405–420.
  3. Brookes GB: Vitamin D deficiency and deafness: 1984 update. Am J Otol 1985;6:102–107.
  4. Brookes EB, Morrison AW: Vitamin D deficiency and deafness. BMJ (Clin Res Ed) 1981;283:273–274.
  5. Brown J, Bianco JI, McGrath JJ, Eyles DW: 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 2003;343:139–143.
  6. Bula CM, Huhtakangas J, Olivera C, Bishop JE, Norman AW, Henry HL: Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice. Endocrinology 2005;146:5581–5586.
  7. Burne TH, Johnston AN, McGrath JJ, Mackay-Sim A: Swimming behaviour and post-swimming activity in Vitamin D receptor knockout mice. Brain Res Bull 2006;69:74–78.
  8. Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A: Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 2005;157:299–308.
  9. Carloni S, Carnevali A, Cimino M, Balduini W: Extended role of necrotic cell death after hypoxia-ischemia-induced neurodegeneration in the neonatal rat. Neurobiol Dis 2007;27:354–361.
  10. Cohen HN, Fogelman I, Boyle IT, Doig JA: Deafness due to hypervitaminosis D. Lancet 1979;1:985.
  11. de la Mothe LA, Blumell S, Kajikawa Y, Hackett TA: Thalamic connections of the auditory cortex in marmoset monkeys: core and medial belt regions. J Comp Neurol 2006;496:72–96.
  12. Devlin JT, Sillery EL, Hall DA, Hobden P, Behrens TE, Nunes RG, Clare S, Matthews PM, Moore DR, Johansen-Berg H: Reliable identification of the auditory thalamus using multi-modal structural analyses. Neuroimage 2006;30:1112–1120.
  13. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 2005;289:F8–F28.
  14. Hibino H, Horio Y, Inanobe A, Doi K, Ito M, Yamada M, Gotow T, Uchiyama Y, Kawamura M, Kubo T, Kurachi Y: An ATP-dependent inwardly rectifying potassium channel, KAB-2 (Kir4. 1), in cochlear stria vascularis of inner ear: its specific subcellular localization and correlation with the formation of endocochlear potential. J Neurosci 1997;17:4711–4721.
  15. Holick MF: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362–371.
  16. Holick MF: High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353–373.
  17. Ikeda K, Kobayashi T, Itoh Z, Kusakari J, Takasaka T: Evaluation of vitamin D metabolism in patients with bilateral sensorineural hearing loss. Am J Otol 1989;10:11–13.
  18. Ikeda K, Kobayashi T, Kusakari J, Takasaka T, Yumita S, Furukawa Y: Sensorineural hearing loss associated with hypoparathyroidism. Laryngoscope 1987;97:1075–1079.
  19. Ishida S, Isotani H, Kameoka K, Kishi T: Familial idiopathic hypoparathyroidism, sensorineural deafness and renal dysplasia. Intern Med 2001;40:110–113.
  20. Javaid MK, Crozier SR, Harvey NC, Gale CR, Dennison EM, Boucher BJ, Arden NK, Godfrey KM, Cooper C: Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006;367:36–43.
  21. Kaga K, Yamada K, Tsuzuku T, Uno A: The long-term effect of bilateral inferior colliculus ablation on auditory brainstem response in awake cats. Acta Otolaryngol 1999;119:128–131.
  22. Kalueff A, Loseva E, Haapasalo H, Rantala I, Keranen J, Lou YR, Minasyan A, Keisala T, Miettinen S, Kuuslahti M, Tuchimaa P: Thalamic calcification in vitamin D receptor knockout mice. Neuroreport 2006a;17:717–721.
  23. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P: Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport 2004;15:1271–1274.
  24. Kalueff AV, Minasyan A, Keisala T, Kuuslahti M, Miettinen S, Tuohimaa P: Increased severity of chemically induced seizures in mice with partially deleted vitamin D receptor gene. Neurosci Lett 2006b;394:69–73.
  25. Kamada S, Kikkawa U, Tsujimoto Y, Hunter T: Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s). J Biol Chem 2005;280:857–860.
  26. Kawamura T, Akira T, Watanabe M, Kagitani Y: Prostaglandin E1 prevents apoptotic cell death in superficial dorsal horn of rat spinal cord. Neuropharmacology 1997;36:1023–1030.
  27. Kim J, Chung YD, Park DY, Choi S, Shin DW, Soh H, Lee HW, Son W, Yim J, Park CS, Kernan MJ, Kim C: A TRPV family ion channel required for hearing in Drosophila. Nature 2003;424:81–84.
  28. Lagrutta AA, Bond CT, Xia XM, Pessia M, Tucker S, Adelman JP: Inward rectifier potassium channels. Cloning, expression and structure-function studies. Jpn Heart J 1996;37:651–660.
  29. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB: Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998;139:4391–4396.
  30. Liedtke W, Choe Y, Marti-Renom MA, Bell AM, Denis CS, Sali A, Hudspeth AJ, Friedman JM, Heller S: Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000;103:525–535.
  31. Liedtke W, Tobin DM, Bargmann CI, Friedman JM: Mammalian TRPV4 (VR-OAC) directs behavioral responses to osmotic and mechanical stimuli in Caenorhabditis elegans. Proc Natl Acad Sci USA 2003;100(suppl 2):14531–14536.
  32. Lou YR, Qiao S, Talonpoika R, Syvala H, Tuohimaa P: The role of vitamin D3 metabolism in prostate cancer. J Steroid Biochem Mol Biol 2004;92:317–325.
  33. Mangelsdorf DJ, Evans RM: The RXR heterodimers and orphan receptors. Cell 1995;83:841–850.
  34. McGrath JJ, Feron FP, Burne TH, Mackay-Sim A, Eyles DW: Vitamin D3-implications for brain development. J Steroid Biochem Mol Biol 2004;89–90:557–560.
  35. Morishita H, Makishima T, Kaneko C, Lee YS, Segil N, Takahashi K, Kuraoka A, Nakagawa T, Nabekura J, Nakayama K, Nakayama KI: Deafness due to degeneration of cochlear neurons in caspase-3-deficient mice. Biochem Biophys Res Commun 2001;284:142–149.
  36. Nijenhuis T, Hoenderop JG, van der Kemp AW, Bindels RJ: Localization and regulation of the epithelial Ca2+ channel TRPV6 in the kidney. J Am Soc Nephrol 2003;14:2731–2740.
  37. Ohlemiller KK, Gagnon PM: Apical-to-basal gradients in age-related cochlear degeneration and their relationship to ‘primary’ loss of cochlear neurons. J Comp Neurol 2004a;479:103–116.
  38. Ohlemiller KK, Gagnon PM: Cellular correlates of progressive hearing loss in 129S6/SvEv mice. J Comp Neurol 2004b;469:377–390.
  39. Ouagazzal AM, Reiss D, Romand R: Effects of age-related hearing loss on startle reflex and prepulse inhibition in mice on pure and mixed C57BL and 129 genetic background. Behav Brain Res 2006;172:307–315.
  40. Pearson JM, Crocker WD, Fitzpatrick DC: Connections of functional areas in the mustached bat’s auditory cortex with the auditory thalamus. J Comp Neurol 2007;500:401–418.
  41. Petersen MB, Willems PJ: Non-syndromic, autosomal-recessive deafness. Clin Genet 2006;69:371–392.
  42. Reimann F, Ashcroft FM: Inwardly rectifying potassium channels. Curr Opin Cell Biol 1999;11:503–508.
  43. Riva C, Donadieu E, Magnan J, Lavieille JP: Age-related hearing loss in CD/1 mice is associated to ROS formation and HIF target proteins up-regulation in the cochlea. Exp Gerontol 2007;42:327–336.
  44. Shen J, Harada N, Kubo N, Liu B, Mizuno A, Suzuki M, Yamashita T: Functional expression of transient receptor potential vanilloid 4 in the mouse cochlea. Neuroreport 2006;17:135–139.
  45. Sigalovsky IS, Melcher JR: Effects of sound level on fMRI activation in human brainstem, thalamic and cortical centers. Hear Res 2006;215:67–76.
  46. Song Y, Kato S, Fleet JC: Vitamin D receptor (VDR) knockout mice reveal VDR-independent regulation of intestinal calcium absorption and ECaC2 and calbindin D9k mRNA. J Nutr 2003;133:374–380.
  47. Tabuchi K, Suzuki M, Mizuno A, Hara A: Hearing impairment in TRPV4 knockout mice. Neurosci Lett 2005;382:304–308.
  48. Takahashi K, Kamiya K, Urase K, Suga M, Takizawa T, Mori H, Yoshikawa Y, Ichimura K, Kuida K, Momoi T: Caspase-3-deficiency induces hyperplasia of supporting cells and degeneration of sensory cells resulting in the hearing loss. Brain Res 2001;894:359–367.
  49. Takayanagi M, Ojima H: Microtopography of the dual corticothalamic projections originating from domains along the frequency axis of the cat primary auditory cortex. Neuroscience 2006;142:769–780.
  50. Takeuchi S, Ando M, Kakigi A: Mechanism generating endocochlear potential: role played by intermediate cells in stria vascularis. Biophys J 2000;79:2572–2582.
  51. Taniura H, Ito M, Sanada N, Kuramoto N, Ohno Y, Nakamichi N, Yoneda Y: Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res 2006;83:1179–1189.
  52. Veenstra TD, Prufer K, Koenigsberger C, Brimijoin SW, Grande JP, Kumar R: 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo. Brain Res 1998;804:193–205.
  53. Wong CK, Chen Z, So KL, Li D, Li P: Polycomb group protein RING1B is a direct substrate of caspases-3 and -9. Biochim Biophys Acta 2007;1773:844–852.
  54. Yamada K, Kaga K, Tsuzuku T, Uno A: Long-term changes in middle latency response and evidence of retrograde degeneration in the medial geniculate body after auditory cortical ablation in cats. Acta Otolaryngol 2000;120:744–749.
  55. Ylikomi T, Laaksi I, Lou YR, Martikainen P, Miettinen S, Pennanen P, Purmonen S, Syvala H, Vienonen A, Tuohimaa P: Antiproliferative action of vitamin D. Vitam Horm 2002;64:357–406.
  56. Zhang Y, Zhu W, Wang YG, Liu XJ, Jiao L, Liu X, Zhang ZH, Lu CL, He C: Interaction of SH2-Bbeta with RET is involved in signaling of GDNF-induced neurite outgrowth. J Cell Sci 2006;119:1666–1676.
  57. Zheng QY, Johnson KR, Erway LC: Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 1999;130:94–107.
  58. Ziporyn T: Possible link probed: deafness and vitamin D. JAMA 1983;250:1951–1952.
  59. Zittermann A: Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003;89:552–572.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: July 13, 2007
Accepted: October 19, 2007
Published online: February 07, 2008
Issue release date: June 2008

Number of Print Pages: 12
Number of Figures: 6
Number of Tables: 1

ISSN: 1420-3030 (Print)
eISSN: 1421-9700 (Online)

For additional information: https://www.karger.com/AUD


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP